查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1518814

數位病理市場：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2031 年

Digital Pathology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 249 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發佈了一份關於全球數位病理市場的綜合報告。該報告全面評估了主要市場動態，包括驅動因素、趨勢、機會和課題，並提供了有關市場結構的詳細見解。

重要見解

  • 數位病理市場規模（2024年）：81億美元
  • 預計市值（2031年）：195億美元
  • 全球市場成長率（2024-2031年複合年增長率）：13.5%

數位病理學市場—研究範圍：

數位病理學涉及在數位環境中捕獲、管理、共享和解釋病理資訊。數位病理學系統使用透過掃瞄傳統載玻片創建的虛擬載玻片來提供高解析度影像以進行分析和診斷。這項技術對於各種應用都極為重要，包括初級診斷、診斷諮詢、臨床研究和教育目的。該市場為醫院、診斷實驗室、學術研究機構和製藥公司提供服務，提供各種系統和解決方案，包括全玻片成像 (WSI)、影像分析軟體以及儲存和通訊解決方案。

市場成長動力：

全球數位病理市場由幾個關鍵因素推動，包括擴大採用旨在提高診斷準確性和工作流程效率的數位病理系統。癌症等慢性疾病的盛行率不斷上升，需要準確、及時的診斷，從而推動了對數位病理解決方案的需求。人工智慧 (AI) 和機器學習 (ML) 的整合等技術進步正在提高影像分析和診斷能力並推動市場成長。此外，對個人化醫療的日益關注以及能夠實現遠距診斷和諮詢的遠距病理學服務的擴展正在為市場擴張創造新的途徑。

市場限制因素：

儘管成長前景廣闊，但數位病理市場面臨高實施成本、資料安全問題和監管合規性等課題。數位病理系統（例如掃瞄器、軟體和 IT 基礎設施）所需的高額初始投資是採用的障礙，特別是對於中小型實驗室而言。此外，考慮到患者資訊的敏感性，確保數位病理數據的安全性和機密性至關重要。監管標準和合規要求因地區而異，使市場准入和營運流程變得複雜。為了解決這些經濟和監管障礙，行業利益相關者和政策制定者必須共同努力，以促進獲得安全且具有成本效益的數位病理解決方案。

市場機會：

在技術創新、人口趨勢和不斷發展的醫療保健服務模式的推動下，數位病理市場提供了巨大的成長機會。人工智慧和機器學習技術在數位病理診斷中的整合提高了診斷準確性，自動化日常任務，促進預測分析，並開闢了精準醫學的新領域。在通訊基礎設施的進步和遠端診斷解決方案的需求的推動下，遠端病理診斷的上升趨勢擴大了市場範圍和可及性。戰略合作夥伴關係、研發投資以及引入用戶友好且可互通的數位病理系統對於利用新的商機並保持動態數位病理領域的市場領先地位至關重要。

本報告解決的關鍵問題

  • 推動數位病理市場全球成長的關鍵因素是什麼？
  • 哪些系統和應用程式正在推動數位病理學在不同醫療保健環境中的採用？
  • 技術進步如何改變數位病理市場的競爭格局？
  • 誰是數位病理學市場的關鍵參與者？
  • 全球數位病理市場有哪些新趨勢和未來前景？

目錄

第1章 內容提要

第2章 市場概況

  • 市場範圍和定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 任務
    • 主要趨勢
  • 產品類型生命週期分析
  • 數位病理市場：價值鏈
    • 原材料供應商名單
    • 製造商名單
    • 經銷商名單
    • 用途一覽
    • 獲利能力分析
  • 波特五力分析
  • 地緣政治緊張局勢：對市場的影響
  • 宏觀經濟因素
    • 世界產業展望
    • 世界GDP成長展望
    • 全球母公司市場概覽
  • 預測變量 - 相關性和影響
  • 監管和技術格局

第3章 全球數位病理市場展望：實際結果（2019-2023）與預測（2024-2031）

  • 主要亮點
    • 市場規模（單位）預測
    • 市場規模及年成長率
    • 絕對數量機會
  • 市場規模分析及預測（十億美元）
    • 過去的市場規模分析，2019-2023
    • 目前市場規模預測，2024-2031
  • 全球數位病理市場展望：產品類型
    • 簡介/主要發現
    • 2019-2023 年依產品類型劃分的歷史市場規模（十億美元）和數量（單位）分析
    • 2024-2031 年依產品類型劃分的當前市場規模（十億美元）和銷售（單位）預測
  • 市場吸引力分析：產品類型
  • 全球數位病理市場展望：應用
    • 簡介/主要發現
    • 2019-2023 年依應用劃分的歷史市場規模（十億美元）和數量（單位）分析
    • 2024-2031 年依應用劃分的當前市場規模（十億美元）和數量（單位）預測
  • 市場吸引力分析：應用
  • 全球數位病理市場展望：最終用戶
    • 簡介/主要發現
    • 2019-2023 年最終用戶歷史市場規模（十億美元）與數量（單位）分析
    • 2024-2031 年最終用戶當前市場規模（十億美元）和數量（單位）預測
  • 市場吸引力分析：最終用戶

第4章 全球數位病理市場展望：地區

  • 主要亮點
  • 2019-2023 年依地區歷史市場規模（十億美元）和數量（單位）分析
  • 2024-2031 年依地區劃分的當前市場規模（十億美元）和銷售量（單位）預測
    • 北美
    • 歐洲
    • 東亞
    • 南亞/大洋洲
    • 拉丁美洲
    • 中東和非洲 (MEA)
  • 市場吸引力分析：區域

第5章 北美數位病理市場展望：實際（2019-2023）與預測（2024-2031）

第6章 歐洲數位病理市場展望：實際（2019-2023）與預測（2024-2031）

第7章 東亞數位病理市場展望：實際（2019-2023）與預測（2024-2031）

第8章 南亞和大洋洲數位病理市場展望：實際結果（2019-2023）和預測（2024-2031）

第9章 拉丁美洲數位病理市場展望：實際（2019-2023）與預測（2024-2031）

第10章 中東和非洲數位病理市場展望：實際（2019-2023）和預測（2024-2031）

第11章 競爭格局

  • 2024 年市場佔有率分析
  • 市場結構
    • 競爭加劇地圖：依市場劃分
    • 有競爭力的模擬IC
    • 表觀產品類型容量
  • 公司簡介（詳細資訊 - 概述、財務狀況、策略、最新發展）
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Huron Technologies International Inc.
    • Koninklijke Philips NV
    • Olympus Corporation
    • Hamamatsu Photonics KK
    • Carl Zeiss AG
    • Nikon Corporation
    • 3DHISTECH Ltd.
    • Hologic Inc.
    • PerkinElmer, Inc.
    • Visiopharm
    • OptraSCAN, Inc.
    • Inspirata, Inc.
    • Sectra AB

第12章 附錄

  • 調查方法
  • 調查先決條件
  • 縮寫
簡介目錄
Product Code: PMRREP33922

Persistence Market Research has recently released a comprehensive report on the worldwide market for digital pathology. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Digital Pathology Market Size (2024E): USD 8.1 Bn
  • Projected Market Value (2031F): USD 19.5 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 13.5%

Digital Pathology Market - Report Scope:

Digital pathology involves the acquisition, management, sharing, and interpretation of pathology information in a digital environment. Digital pathology systems use virtual slides created by scanning conventional glass slides and provide high-resolution images for analysis and diagnosis. This technology is pivotal in various applications, including primary diagnosis, diagnostic consultation, clinical research, and educational purposes. The market caters to hospitals, diagnostic laboratories, academic and research institutions, and pharmaceutical companies, offering a range of systems and solutions, such as whole slide imaging (WSI), image analysis software, and storage and communication solutions.

Market Growth Drivers:

The global digital pathology market is propelled by several key factors, including the growing adoption of digital pathology systems to enhance diagnostic accuracy and workflow efficiency. The rising prevalence of chronic diseases, such as cancer, necessitates accurate and timely diagnosis, driving demand for digital pathology solutions. Technological advancements, such as artificial intelligence (AI) and machine learning (ML) integration, improve image analysis and diagnostic capabilities, fostering market growth. Moreover, the increasing focus on personalized medicine and the expansion of telepathology services, which enable remote diagnosis and consultation, create new avenues for market expansion.

Market Restraints:

Despite promising growth prospects, the digital pathology market faces challenges related to high implementation costs, data security concerns, and regulatory compliance. The initial investment required for digital pathology systems, including scanners, software, and IT infrastructure, can be significant, posing a barrier to adoption, particularly for small and mid-sized laboratories. Additionally, ensuring the security and confidentiality of digital pathology data is critical, given the sensitivity of patient information. Regulatory standards and compliance requirements vary across regions, adding complexity to market entry and operational processes. Addressing these economic and regulatory barriers necessitates collaboration between industry stakeholders and policymakers to promote access to secure and cost-effective digital pathology solutions.

Market Opportunities:

The digital pathology market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of AI and ML technologies in digital pathology enhances diagnostic accuracy, automates routine tasks, and facilitates predictive analytics, opening new frontiers in precision medicine. The growing trend of telepathology, driven by advancements in telecommunication infrastructure and the need for remote diagnostic solutions, expands the market reach and accessibility. Strategic partnerships, investment in research and development, and the introduction of user-friendly, interoperable digital pathology systems are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic digital pathology landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the digital pathology market globally?
  • Which systems and applications are driving digital pathology adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the digital pathology market?
  • Who are the key players contributing to the digital pathology market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global digital pathology market?

Competitive Intelligence and Business Strategy:

Leading players in the global digital pathology market, including Leica Biosystems, Philips Healthcare, and Roche Diagnostics, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced digital pathology solutions, including AI-powered image analysis software, high-throughput scanners, and cloud-based platforms, catering to diverse clinical and research needs. Collaborations with healthcare providers, academic institutions, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and pathologist education fosters market growth and enhances diagnostic outcomes in the rapidly evolving digital pathology landscape.

Key Companies Profiled:

  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Huron Technologies International Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • Hamamatsu Photonics K.K.
  • Carl Zeiss AG
  • Nikon Corporation
  • 3DHISTECH Ltd.
  • Hologic Inc.
  • PerkinElmer, Inc.
  • Visiopharm
  • OptraSCAN, Inc.
  • Inspirata, Inc.
  • Sectra AB

Digital Pathology Market Research Segmentation

By Product Type:

  • Digital Pathology Equipment
  • Digital Pathology Software
  • Digital Pathology Services

By Application:

  • Clinical Pathology
  • Molecular Diagnostics
  • Basic & Applied Research
  • Drug Development

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Forensic Laboratories
  • Research Institutes
  • Contract Research Organizations (CROs)
  • Clinics

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Digital Pathology Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Type Lifecycle Analysis
  • 2.4. Digital Pathology Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Digital Pathology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Bn ) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019-2023
    • 3.2.2. Current Market Size Forecast, 2024-2031
  • 3.3. Global Digital Pathology Market Outlook: Product Type
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Product Type, 2019-2023
    • 3.3.3. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Product Type, 2024-2031
      • 3.3.3.1. Digital Pathology Equipment
        • 3.3.3.1.1. Whole Slide Scanners
        • 3.3.3.1.1.1. Brightfield Slide Scanners
        • 3.3.3.1.1.2. Fluorescence Slide Scanners
        • 3.3.3.1.1.3. Combination Slide Scanners
        • 3.3.3.1.2. Clinical Microscope
        • 3.3.3.1.3. Tissue Microarrays
      • 3.3.3.2. Digital Pathology Software
        • 3.3.3.2.1. Image Viewing and Analysis Software
        • 3.3.3.2.1.1. On-premise
        • 3.3.3.2.1.2. Cloud-based
        • 3.3.3.2.2. Digital Pathology Information Systems
        • 3.3.3.2.2.1. On-premise
        • 3.3.3.2.2.2. Cloud-based
      • 3.3.3.3. Digital Pathology Services
        • 3.3.3.3.1. Installation and Integration Services
        • 3.3.3.3.2. Consulting Services
        • 3.3.3.3.3. Maintenance and Validation Services
  • 3.4. Market Attractiveness Analysis: Product Type
  • 3.5. Global Digital Pathology Market Outlook: Application
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Application, 2019-2023
    • 3.5.3. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Application, 2024-2031
      • 3.5.3.1. Clinical Pathology
      • 3.5.3.2. Molecular Diagnostics
      • 3.5.3.3. Basic & Applied Research
      • 3.5.3.4. Drug Development
      • 3.5.3.5. Others
  • 3.6. Market Attractiveness Analysis: Application
  • 3.7. Global Digital Pathology Market Outlook: End User
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By End User, 2019-2023
    • 3.7.3. Current Market Size (US$ Bn ) and Volume (Units) Forecast By End User, 2024-2031
      • 3.7.3.1. Hospitals
      • 3.7.3.2. Diagnostic Laboratories
      • 3.7.3.3. Pharmaceutical & Biotechnology Companies
      • 3.7.3.4. Forensic Laboratories
      • 3.7.3.5. Research Institutes
      • 3.7.3.6. Contract Research Organizations (CROs)
      • 3.7.3.7. Clinics
  • 3.8. Market Attractiveness Analysis: End User

4. Global Digital Pathology Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Region, 2019-2023
  • 4.3. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Region, 2024-2031
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Digital Pathology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Market, 2019-2023
    • 5.3.1. By Country
    • 5.3.2. By Product Type
    • 5.3.3. By Application
    • 5.3.4. By End User
  • 5.4. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Country, 2024-2031
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Product Type, 2024-2031
    • 5.5.1. Digital Pathology Equipment
      • 5.5.1.1. Whole Slide Scanners
        • 5.5.1.1.1. Brightfield Slide Scanners
        • 5.5.1.1.2. Fluorescence Slide Scanners
        • 5.5.1.1.3. Combination Slide Scanners
      • 5.5.1.2. Clinical Microscope
      • 5.5.1.3. Tissue Microarrays
    • 5.5.2. Digital Pathology Software
      • 5.5.2.1. Image Viewing and Analysis Software
        • 5.5.2.1.1. On-premise
        • 5.5.2.1.2. Cloud-based
      • 5.5.2.2. Digital Pathology Information Systems
        • 5.5.2.2.1. On-premise
        • 5.5.2.2.2. Cloud-based
    • 5.5.3. Digital Pathology Services
      • 5.5.3.1. Installation and Integration Services
      • 5.5.3.2. Consulting Services
      • 5.5.3.3. Maintenance and Validation Services
  • 5.6. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Application, 2024-2031
    • 5.6.1. Clinical Pathology
    • 5.6.2. Molecular Diagnostics
    • 5.6.3. Basic & Applied Research
    • 5.6.4. Drug Development
    • 5.6.5. Others
  • 5.7. Current Market Size (US$ Bn ) and Volume (Units) Forecast By End User, 2024-2031
    • 5.7.1. Hospitals
    • 5.7.2. Diagnostic Laboratories
    • 5.7.3. Pharmaceutical & Biotechnology Companies
    • 5.7.4. Forensic Laboratories
    • 5.7.5. Research Institutes
    • 5.7.6. Contract Research Organizations (CROs)
    • 5.7.7. Clinics
  • 5.8. Market Attractiveness Analysis

6. Europe Digital Pathology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Market, 2019-2023
    • 6.3.1. By Country
    • 6.3.2. By Product Type
    • 6.3.3. By Application
    • 6.3.4. By End User
  • 6.4. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Country, 2024-2031
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Product Type, 2024-2031
    • 6.5.1. Digital Pathology Equipment
      • 6.5.1.1. Whole Slide Scanners
        • 6.5.1.1.1. Brightfield Slide Scanners
        • 6.5.1.1.2. Fluorescence Slide Scanners
        • 6.5.1.1.3. Combination Slide Scanners
      • 6.5.1.2. Clinical Microscope
      • 6.5.1.3. Tissue Microarrays
    • 6.5.2. Digital Pathology Software
      • 6.5.2.1. Image Viewing and Analysis Software
        • 6.5.2.1.1. On-premise
        • 6.5.2.1.2. Cloud-based
      • 6.5.2.2. Digital Pathology Information Systems
        • 6.5.2.2.1. On-premise
        • 6.5.2.2.2. Cloud-based
    • 6.5.3. Digital Pathology Services
      • 6.5.3.1. Installation and Integration Services
      • 6.5.3.2. Consulting Services
      • 6.5.3.3. Maintenance and Validation Services
  • 6.6. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Application, 2024-2031
    • 6.6.1. Clinical Pathology
    • 6.6.2. Molecular Diagnostics
    • 6.6.3. Basic & Applied Research
    • 6.6.4. Drug Development
    • 6.6.5. Others
  • 6.7. Current Market Size (US$ Bn ) and Volume (Units) Forecast By End User, 2024-2031
    • 6.7.1. Hospitals
    • 6.7.2. Diagnostic Laboratories
    • 6.7.3. Pharmaceutical & Biotechnology Companies
    • 6.7.4. Forensic Laboratories
    • 6.7.5. Research Institutes
    • 6.7.6. Contract Research Organizations (CROs)
    • 6.7.7. Clinics
  • 6.8. Market Attractiveness Analysis

7. East Asia Digital Pathology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Market, 2019-2023
    • 7.3.1. By Country
    • 7.3.2. By Product Type
    • 7.3.3. By Application
    • 7.3.4. By End User
  • 7.4. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Country, 2024-2031
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Product Type, 2024-2031
    • 7.5.1. Digital Pathology Equipment
      • 7.5.1.1. Whole Slide Scanners
        • 7.5.1.1.1. Brightfield Slide Scanners
        • 7.5.1.1.2. Fluorescence Slide Scanners
        • 7.5.1.1.3. Combination Slide Scanners
      • 7.5.1.2. Clinical Microscope
      • 7.5.1.3. Tissue Microarrays
    • 7.5.2. Digital Pathology Software
      • 7.5.2.1. Image Viewing and Analysis Software
        • 7.5.2.1.1. On-premise
        • 7.5.2.1.2. Cloud-based
      • 7.5.2.2. Digital Pathology Information Systems
        • 7.5.2.2.1. On-premise
        • 7.5.2.2.2. Cloud-based
    • 7.5.3. Digital Pathology Services
      • 7.5.3.1. Installation and Integration Services
      • 7.5.3.2. Consulting Services
      • 7.5.3.3. Maintenance and Validation Services
  • 7.6. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Application, 2024-2031
    • 7.6.1. Clinical Pathology
    • 7.6.2. Molecular Diagnostics
    • 7.6.3. Basic & Applied Research
    • 7.6.4. Drug Development
    • 7.6.5. Others
  • 7.7. Current Market Size (US$ Bn ) and Volume (Units) Forecast By End User, 2024-2031
    • 7.7.1. Hospitals
    • 7.7.2. Diagnostic Laboratories
    • 7.7.3. Pharmaceutical & Biotechnology Companies
    • 7.7.4. Forensic Laboratories
    • 7.7.5. Research Institutes
    • 7.7.6. Contract Research Organizations (CROs)
    • 7.7.7. Clinics
  • 7.8. Market Attractiveness Analysis

8. South Asia & Oceania Digital Pathology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Market, 2019-2023
    • 8.3.1. By Country
    • 8.3.2. By Product Type
    • 8.3.3. By Application
    • 8.3.4. By End User
  • 8.4. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Country, 2024-2031
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Product Type, 2024-2031
    • 8.5.1. Digital Pathology Equipment
      • 8.5.1.1. Whole Slide Scanners
        • 8.5.1.1.1. Brightfield Slide Scanners
        • 8.5.1.1.2. Fluorescence Slide Scanners
        • 8.5.1.1.3. Combination Slide Scanners
      • 8.5.1.2. Clinical Microscope
      • 8.5.1.3. Tissue Microarrays
    • 8.5.2. Digital Pathology Software
      • 8.5.2.1. Image Viewing and Analysis Software
        • 8.5.2.1.1. On-premise
        • 8.5.2.1.2. Cloud-based
      • 8.5.2.2. Digital Pathology Information Systems
        • 8.5.2.2.1. On-premise
        • 8.5.2.2.2. Cloud-based
    • 8.5.3. Digital Pathology Services
      • 8.5.3.1. Installation and Integration Services
      • 8.5.3.2. Consulting Services
      • 8.5.3.3. Maintenance and Validation Services
  • 8.6. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Application, 2024-2031
    • 8.6.1. Clinical Pathology
    • 8.6.2. Molecular Diagnostics
    • 8.6.3. Basic & Applied Research
    • 8.6.4. Drug Development
    • 8.6.5. Others
  • 8.7. Current Market Size (US$ Bn ) and Volume (Units) Forecast By End User, 2024-2031
    • 8.7.1. Hospitals
    • 8.7.2. Diagnostic Laboratories
    • 8.7.3. Pharmaceutical & Biotechnology Companies
    • 8.7.4. Forensic Laboratories
    • 8.7.5. Research Institutes
    • 8.7.6. Contract Research Organizations (CROs)
    • 8.7.7. Clinics
  • 8.8. Market Attractiveness Analysis

9. Latin America Digital Pathology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Market, 2019-2023
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By Application
    • 9.3.4. By End User
  • 9.4. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Country, 2024-2031
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Product Type, 2024-2031
    • 9.5.1. Digital Pathology Equipment
      • 9.5.1.1. Whole Slide Scanners
        • 9.5.1.1.1. Brightfield Slide Scanners
        • 9.5.1.1.2. Fluorescence Slide Scanners
        • 9.5.1.1.3. Combination Slide Scanners
      • 9.5.1.2. Clinical Microscope
      • 9.5.1.3. Tissue Microarrays
    • 9.5.2. Digital Pathology Software
      • 9.5.2.1. Image Viewing and Analysis Software
        • 9.5.2.1.1. On-premise
        • 9.5.2.1.2. Cloud-based
      • 9.5.2.2. Digital Pathology Information Systems
        • 9.5.2.2.1. On-premise
        • 9.5.2.2.2. Cloud-based
    • 9.5.3. Digital Pathology Services
      • 9.5.3.1. Installation and Integration Services
      • 9.5.3.2. Consulting Services
      • 9.5.3.3. Maintenance and Validation Services
  • 9.6. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Application, 2024-2031
    • 9.6.1. Clinical Pathology
    • 9.6.2. Molecular Diagnostics
    • 9.6.3. Basic & Applied Research
    • 9.6.4. Drug Development
    • 9.6.5. Others
  • 9.7. Current Market Size (US$ Bn ) and Volume (Units) Forecast By End User, 2024-2031
    • 9.7.1. Hospitals
    • 9.7.2. Diagnostic Laboratories
    • 9.7.3. Pharmaceutical & Biotechnology Companies
    • 9.7.4. Forensic Laboratories
    • 9.7.5. Research Institutes
    • 9.7.6. Contract Research Organizations (CROs)
    • 9.7.7. Clinics
  • 9.8. Market Attractiveness Analysis

10. Middle East & Africa Digital Pathology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Bn ) and Volume (Units) Analysis By Market, 2019-2023
    • 10.3.1. By Country
    • 10.3.2. By Product Type
    • 10.3.3. By Application
    • 10.3.4. By End User
  • 10.4. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Country, 2024-2031
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Product Type, 2024-2031
    • 10.5.1. Digital Pathology Equipment
      • 10.5.1.1. Whole Slide Scanners
        • 10.5.1.1.1. Brightfield Slide Scanners
        • 10.5.1.1.2. Fluorescence Slide Scanners
        • 10.5.1.1.3. Combination Slide Scanners
      • 10.5.1.2. Clinical Microscope
      • 10.5.1.3. Tissue Microarrays
    • 10.5.2. Digital Pathology Software
      • 10.5.2.1. Image Viewing and Analysis Software
        • 10.5.2.1.1. On-premise
        • 10.5.2.1.2. Cloud-based
      • 10.5.2.2. Digital Pathology Information Systems
        • 10.5.2.2.1. On-premise
        • 10.5.2.2.2. Cloud-based
    • 10.5.3. Digital Pathology Services
      • 10.5.3.1. Installation and Integration Services
      • 10.5.3.2. Consulting Services
      • 10.5.3.3. Maintenance and Validation Services
  • 10.6. Current Market Size (US$ Bn ) and Volume (Units) Forecast By Application, 2024-2031
    • 10.6.1. Clinical Pathology
    • 10.6.2. Molecular Diagnostics
    • 10.6.3. Basic & Applied Research
    • 10.6.4. Drug Development
    • 10.6.5. Others
  • 10.7. Current Market Size (US$ Bn ) and Volume (Units) Forecast By End User, 2024-2031
    • 10.7.1. Hospitals
    • 10.7.2. Diagnostic Laboratories
    • 10.7.3. Pharmaceutical & Biotechnology Companies
    • 10.7.4. Forensic Laboratories
    • 10.7.5. Research Institutes
    • 10.7.6. Contract Research Organizations (CROs)
    • 10.7.7. Clinics
  • 10.8. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2024
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Analog IC
    • 11.2.3. Apparent Product Type Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Danaher Corporation
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product Type
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. F. Hoffmann-La Roche AG
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product Type
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Huron Technologies International Inc.
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product Type
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Koninklijke Philips N.V.
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product Type
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Olympus Corporation
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product Type
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. Hamamatsu Photonics K.K.
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product Type
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Carl Zeiss AG
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product Type
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Nikon Corporation
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product Type
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. 3DHISTECH Ltd.
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product Type
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Hologic Inc.
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product Type
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. PerkinElmer, Inc.
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product Type
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy
    • 11.3.12. Visiopharm
      • 11.3.12.1. Overview
      • 11.3.12.2. Segments and Product Type
      • 11.3.12.3. Key Financials
      • 11.3.12.4. Market Developments
      • 11.3.12.5. Market Strategy
    • 11.3.13. OptraSCAN, Inc.
      • 11.3.13.1. Overview
      • 11.3.13.2. Segments and Product Type
      • 11.3.13.3. Key Financials
      • 11.3.13.4. Market Developments
      • 11.3.13.5. Market Strategy
    • 11.3.14. Inspirata, Inc.
      • 11.3.14.1. Overview
      • 11.3.14.2. Segments and Product Type
      • 11.3.14.3. Key Financials
      • 11.3.14.4. Market Developments
      • 11.3.14.5. Market Strategy
    • 11.3.15. Sectra AB
      • 11.3.15.1. Overview
      • 11.3.15.2. Segments and Product Type
      • 11.3.15.3. Key Financials
      • 11.3.15.4. Market Developments
      • 11.3.15.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations